Moving targets: Emerging roles for MMPs in cancer progression and metastasis

Gemma Shay1, Conor C Lynch1, Barbara Fingleton2

  • 1Dept. of Tumor Biology, H. Lee Moffitt Cancer Center and Research Institute, 12902 Magnolia Drive, Tampa, FL 33612, USA.

Insights

Matrix metalloproteinases (MMPs) were unsuccessfully targeted in cancer trials. Newer MMP roles in cancer and novel therapeutic strategies offer potential clinical benefits beyond initial inhibitor approaches.

Area of Science:

  • Oncology
  • Biochemistry
  • Enzymology

Background:

  • Matrix metalloproteinases (MMPs) are implicated in cancer progression.
  • Previous clinical trials using small molecule MMP inhibitors failed across various cancer types.

Purpose of the Study:

  • To explore novel roles of MMPs in cancer beyond those targeted by early inhibitors.
  • To identify new clinical applications for targeting MMP activity in cancer patients.

Main Methods:

  • Review of recent scientific literature on MMPs in cancer.
  • Analysis of emerging MMP functions and their relevance to tumor biology.
  • Exploration of innovative therapeutic strategies targeting MMPs.

Main Results:

  • Identified new cancer-associated functions of MMPs not addressed by prior inhibitor studies.
  • Highlighted patient populations and tumor types where MMPs may play distinct roles.
  • Proposed novel approaches for leveraging MMP activity for therapeutic benefit.

Conclusions:

  • The failure of early MMP inhibitors does not negate their potential in cancer therapy.
  • Understanding novel MMP roles is crucial for developing effective cancer treatments.
  • New strategies targeting MMPs could offer clinical benefits for cancer patients.

Related Concept Videos

Role of Matrix Metalloproteases in Degradation of ECM01:23

Role of Matrix Metalloproteases in Degradation of ECM

Matrix metalloproteases (MMPs) are enzymes involved in the hydrolysis of proteins and glycoproteins of the extracellular matrix. MMPs are essential for the migration and proliferation of cells through the dense matrix network, throughout embryonic development, and throughout morphogenesis. The first MMP activity discovered was a collagenase in a tadpole's tail undergoing metamorphosis. The active collagen deposition and modifications lead to the morphogenesis of tadpoles into the adult...
3.8K
Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
7.0K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.1K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

1.8K
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
8.3K
Cancer Cell Migration through Invadopodia01:35

Cancer Cell Migration through Invadopodia

Invadosome is a broad category of cell surface structures with proteolytic activity that  degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However,...
3.5K